Specifically, in the PBMCs from RA patients, there was a marked decrease in the production of interferon-gamma (IFN-γ), interleukin-17A (IL-17A), and granulocyte-macrophage colony-stimulating factor (GM-CSF), as illustrated in Figure 3A. The gene discussed is CSF2; the disease is rheumatoid arthritis.